Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Minor injuries to hair follicles can stimulate hair growth in mice by increasing a specific protein.

Minor skin injuries can boost hair growth by increasing TNF-α.

New treatments for Dissecting cellulitis show promise, but more research is needed to understand the disease and establish a standard treatment plan.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Etanercept may not prevent alopecia areata from coming back.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Some drugs used to treat inflammation may cause hair loss.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Some drugs used to treat immune conditions may cause different types of hair loss.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Anti-TNF therapy can cause hair loss and skin issues.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Unmodified fullerene C60 promotes hair growth and may help treat hair loss.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.